1-trichloromethyl-1,2,3,4-tetrahydro-β-carboline increases extracellular serotonin and stimulates hydroxyl radical production in rats

被引:33
作者
Gerlach, M
Xiao, AY
Heim, C
Lan, J
God, R
Feineis, D
Bringmann, G
Riederer, P
Sontag, KH
机构
[1] Univ Wurzburg, Dept Psychiat, Div Clin Neurochem, D-97080 Wurzburg, Germany
[2] Max Planck Inst Expt Med, D-37075 Gottingen, Germany
[3] Univ Wurzburg, Inst Organ Chem, D-97074 Wurzburg, Germany
关键词
1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline; beta-carbolines; hydroxyl radicals; microdialysis; Parkinson's disease; neurotoxins; dopamine; serotonin;
D O I
10.1016/S0304-3940(98)00791-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline (TaClo), a neurotoxin structurally similar to the dopaminergic neurotoxin MPTP, may be formed in humans treated with chloral hydrate or exposed to trichloroethylene, a widely used industrial solvent. Systemically administered TaClo (0.4 mg/kg, i.p.) induced an immediate and transient release of dopamine (DA) and serotonin (5-HT) measured using microdialysis. However, only 5-HT was increased significantly (area under the curve, AUG, for the 1-2 h-period following TaClo administration: 400% compared with the respective control value; 2-3 h-period: 326%). This was followed by a progressive increase in hydroxyl radical formation reflected by higher extracellular concentrations of the hydroxylate product of salicylic acid, 2,3-dihydroxybenzoic acid (AUC for the 1-2 h period following TaClo administration: 182% compared with the respective control value; 2-3 h period: 190%). In contrast, extracellular glutamate and GABA were increased 2-3 h postinjection by 64 and 51%, respectively. These data suggest that TaClo stimulates the generation of hydroxyl free radicals via an acute release of 5-HT and perhaps DA. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 17 条
[1]  
Berman SB, 1997, J NEUROCHEM, V69, P1185
[2]  
Bringmann G, 1995, J NEURAL TRANSM-SUPP, P235
[3]  
Bringmann G, 1995, J NEURAL TRANSM-SUPP, P245
[4]  
Bringmann G, 1996, BIOGENIC AMINES, V12, P83
[5]  
FELDMAN RG, 1979, HDB CLIN NEUROLOGY 1, V36, P457
[6]  
Gerlach M, 1996, ADV NEUROL, V69, P177
[7]   A post mortem study on neurochemical markers of dopaminergic, GABA-ergic and glutamatergic neurons in basal ganglia thalamocortical circuits in Parkinson syndrome [J].
Gerlach, M ;
Gsell, W ;
Kornhuber, J ;
Jellinger, K ;
Krieger, V ;
Pantucek, F ;
Vock, R ;
Riederer, P .
BRAIN RESEARCH, 1996, 741 (1-2) :142-152
[8]  
Grote C, 1995, J NEURAL TRANSM-SUPP, P275
[9]  
HEIM C, 1997, AKT NEUROL S, V24, pS71
[10]  
Janetzky B, 1995, J NEURAL TRANSM-SUPP, P265